YouTube video by Patrick Boyle

SC anifrolumab hits the market

Roche’s Gazyva lupus FDA filing: B-cell anti-CD20 could be new SLE standard of care.

Wealth inequality in the United States is out of control. Here we visualize the issue in a unique way.

But emerging indications for JAK/TYKs may be the story that lasts

You can use YouTube's latest features!

BUSPH EP860

Biosplice announces submission of new drug application to US FDA for treatment of knee osteoarthritis...

Continuing to show up to work at an agency I no longer trust is devastating

A video from Robin Dore, posted on Dec 16, 2025.

The Thinking Game takes you on a journey into the heart of DeepMind, capturing a team striving to unravel the mysteries of intelligence and life itself. Filmed over five years by the award winning…

European Journal of Epidemiology -

BLUEBIKE RIDERSHIP has soared in Greater Boston. While there is no single solution to our many transportation challenges, the growing popularity of

This week, Trump announced funding for AI-driven pediatric cancer research. But don't be fooled. He's already cancelled longstanding research efforts into pediatric cancers, leaving kids and their fam...

Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving stan...